Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tuluo Penyánqing capsule in sequelae of pelvic inflammatory disease
CTR20132498Phase 2Completed
- Sponsor
- Guangzhou Lanyun Pharmaceutical Research
- Start
- Aug 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tuluo Penyánqing capsule, sponsored by Guangzhou Lanyun Pharmaceutical Research. Started Aug 2014; status: completed.
02
Drugs
Tuluo Penyánqing capsule
Beyond the preview
Go deeper on CTR20132498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132498.